期刊文献+

两种方法测定熊去氧胆酸含量的研究

Comparison of two methods for the determination of Ursodeoxycholic acid
下载PDF
导出
摘要 采用高效液相色谱法和酸碱滴定法对熊去氧胆酸进行含量测定。以DiamonsilTMC18柱为色谱柱,采用乙腈∶0.001 mol/L磷酸二氢钾溶液(50∶50,用磷酸调节pH值至2.0)为流动相,流速1.0 mL/min,检测波长为205 nm;采用氢氧化钠液(0.1 mol/L)为滴定液,中性乙醇为溶剂,酚酞为指示液,进行酸碱滴定。两种方法测定结果基本一致。用高效液相色谱法熊去氧胆酸在0.075 4~2.262 mg/mL与峰面积呈良好的线性关系(r=0.999 7,n=6),平均回收率为99.2%,RSD=0.5%;酸碱滴定法重现性良好,RSD=0.23%。采用高效液相色谱法专属性强、准确;采用酸碱滴定操作简便、准确、重现性好。 To determine the content of Ursodeoxycholic acid by HPLC and acid-base titration.HPLC was performed on DiamonsilTM C18.The mobile phase was acetonitrile ∶ 0.001 mol/L sodium dihydrogen phosphate solution(50 ∶ 50,adjust pH 2.0 with H2PO4)at a flow rate of 1.0 mL/min,the detective wavelength was 205 nm;Using sodium hydroxide titration solution(0.1 mol/L)as the titrant,neutral alcohol as solvent,phenolphthalein indicator solution for acid-base titration.The results of the two methods showed no difference.The good linear relationship was 0.075 4~2.262 mg/mL(r=0.999 7,n=6)and the average recovery was 99.2% and RSD was 0.5% by HPLC.Acid-base titration method was good reproducibility and RSD was 0.23%.HPLC is specific,accurate;acid-base titration is simple,feasible and reproducible.
出处 《应用化工》 CAS CSCD 2013年第8期1527-1528,1547,共3页 Applied Chemical Industry
基金 湖南省自然科学基金项目(13JJ3099) 湖南省科技计划项目(2012SK3134)
关键词 高效液相色谱法 熊去氧胆酸 酸碱滴定法 HPLC Ursodeoxycholic acid acid-base titration
  • 相关文献

参考文献2

二级参考文献26

  • 1Beuers U,Boyer JL,Paumgartner G.Ursodeoxycholic acid in cholestasis: potential mechanisms of action and thepapeitic applications[J].Hepatology,1998,28(6):1449
  • 2Kowdley KV.Ursodeoxycholic acid therapy in the hepatobiliary disease[J].Am J Med,2000,108(6):481
  • 3Papatheodoridis GV,Hadziyannis ES,Deutsch M,et al.Ursodeoxycholic acid for primary biliary cirrhosis:final results of a 12-year,prospective,randomized,controlled trial[J].Am J Gastroenterol,2002,97(8):2063
  • 4Ursodeoxycholic acid:a second look.Primary biliary cirrhosis:dashed hopes[J].Prescrire Int,2002,11(59):67
  • 5Mazzella G,Nicola R,Francesco A,et al.Ursodeoxycholic acid administration in patients with cholestasis of pregnancy:effects on primary bile acid in babies and mothers[J].Hepatology,2001,33(3):504
  • 6Czaja AJ.Treatment strategies in autoimmune hepatitis[J].Clin Liver Dis,2002,6(3):511
  • 7Jenkins JK,Boothby LA.Treatment of itching associated with intranhepatic cholestasis of pregnancy[J].Ann Pharmacother,2002,36(9):1462
  • 8Kojima M,Kamoi K,Ukimura O,et al.Clinical utility of ursodeoxycholic acid in preventing flutamide-induced hepatopathy in patients with prostate cancer:a preliminary study[J].Int J Urol,2002,9(1):42
  • 9Boncher E,Guyader D,Jacquelinet S,et al.Interferon and ursodeoxycholic acid combined therapy in chronic viral C hepatitis:controlled randomized trial in 203 patients[J].Dig Liver Dis,2000,32(1):29
  • 10Mazur W,Machniak M,Mazurek U,et al.Interferon versus interferon and UDCA combined therapy in chronic hepatitis C[J].Med Sci Monit,2001,7(s1):157

共引文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部